Orchard Therapeutics plc
ORTX
Cena:
Valuace
70
Růst
53
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
ORCHARD THERAPEUTICS CELEBRATES ADDITION OF METACHROMATIC LEUKODYSTROPHY TO THE U.S. RECOMMENDED UNIFORM SCREENING PANEL
16-12-2025
NEWBORN SCREENING IS THE ONLY PRACTICAL MEANS OF DIAGNOSING MLD PRIOR TO THE ONSET OF SYMPTOMS, WHIC...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES LAST PATIENT TREATED IN REGISTRATIONAL TRIAL OF OTL-203 FOR MPS-I HURLER SYNDROME
07-07-2025
COMPLETION OF ENROLLMENT ACHIEVED NEARLY ONE YEAR AHEAD OF SCHEDULE PRIMARY ANALYSIS ANTICIPATED TWO...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES REIMBURSEMENT AGREEMENT IN SPAIN
28-02-2025
LONDON, MADRID, AND BOSTON, FEB. 28, 2025 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS, A KYOWA KIRIN ...
Více zde
ORCHARD THERAPEUTICS APPOINTS ROBIN KENSELAAR TO CHIEF COMMERCIAL OFFICER AND ANNOUNCES MULTIPLE BUSINESS UPDATES PERTAINING TO ITS APPROVED HSC GENE THERAPY FOR MLD
12-02-2025
FIRST U.S. PATIENTS BEING TREATED WITH LENMELDY™ (ATIDARSAGENE AUTOTEMCEL) IN A COMMERCIAL SETTING...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE DATA PRESENTATIONS AND RECEIVES 2025 NEW TREATMENT AWARD AT THE 21ST ANNUAL WORLDSYMPOSIUM™
03-02-2025
FEATURED DATA SHOWCASE THE TRANSFORMATIVE POTENTIAL OF HSC GENE THERAPY TO ENABLE CROSS-CORRECTION A...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE DATA PRESENTATIONS AND PUBLICATIONS
23-10-2024
TEN PRESENTATIONS AT ESGCT 2024 DETAIL THE THERAPEUTIC POTENTIAL AND APPLICABILITY OF THE COMPANY'S ...
Více zde
ORCHARD THERAPEUTICS AND ER-KIM ANNOUNCE PARTNERSHIP TO BROADEN ACCESS TO LIBMELDY TO ELIGIBLE PATIENTS IN TURKEY AND CERTAIN EURASIAN COUNTRIES
07-10-2024
ISTANBUL AND LONDON, AND BOSTON, OCT. 07, 2024 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS, RECENTLY AC...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE PRESENTATIONS FROM ACROSS ITS LATE-STAGE NEUROMETABOLIC PORTFOLIO AT SSIEM 2024
28-08-2024
LONDON AND BOSTON, AUG. 28, 2024 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS, RECENTLY ACQUIRED BY KYOW...
Více zde
ORCHARD THERAPEUTICS CELEBRATES GLOBAL PROGRESS TOWARD ADVANCING NEWBORN SCREENING FOR MLD ON INTERNATIONAL NEONATAL SCREENING DAY
28-06-2024
A NOMINATION TO ADD MLD TO THE U.S. RECOMMENDED UNIFORM SCREENING PANEL HAS BEEN SUBMITTED BY A MULT...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE PRESENTATIONS AT ASGCT 2024
07-05-2024
EIGHT PRESENTATIONS SHOWCASE THE BROAD APPLICABILITY OF HSC GENE THERAPY TO ADDRESS RARE NEUROMETABO...
Více zde
ORCHARD THERAPEUTICS CO-FOUNDER AND CHIEF EXECUTIVE OFFICER DR. BOBBY GASPAR NAMED TO INAUGURAL 2024 TIME100 HEALTH LIST
03-05-2024
TOKYO, LONDON AND BOSTON, MAY 03, 2024 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS, RECENTLY ACQUIRED B...
Více zde
ORCHARD THERAPEUTICS OUTLINES U.S. LAUNCH PLANS FOR LENMELDY™ (ATIDARSAGENE AUTOTEMCEL), THE ONLY APPROVED THERAPY FOR CHILDREN WITH EARLY-ONSET METACHROMATIC LEUKODYSTROPHY
20-03-2024
FIVE SPECIALIZED TREATMENT CENTERS BEING QUALIFIED ACROSS THE U.S. TO MINIMIZE TRAVEL BURDEN ON ELIG...
Více zde
ORCHARD THERAPEUTICS RECEIVES FDA APPROVAL OF LENMELDY™ (ATIDARSAGENE AUTOTEMCEL), THE ONLY THERAPY FOR ELIGIBLE CHILDREN WITH EARLY-ONSET METACHROMATIC LEUKODYSTROPHY IN THE U.S.
18-03-2024
ONE-TIME TREATMENT WITH LENMELDY HAS SHOWN THE POTENTIAL TO RESTORE ENZYMATIC FUNCTION TO STOP OR SL...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES FIRST PATIENT RANDOMIZED IN REGISTRATIONAL TRIAL OF OTL-203 FOR MPS-I HURLER SYNDROME
05-02-2024
GENE THERAPY BEING DEVELOPED AS A ONE-TIME TREATMENT TO ADDRESS THE UNDERLYING CAUSE OF THE DISEASE ...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE PRESENTATIONS AT THE 20TH ANNUAL WORLDSYMPOSIUM
02-02-2024
THREE ORAL PRESENTATIONS AND SEVEN POSTERS HIGHLIGHT TRANSFORMATIVE POTENTIAL OF HSC GENE THERAPY AN...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES AGREEMENT WITH THE BENELUXA CONSORTIUM ENABLING REIMBURSED ACCESS TO LIBMELDY
25-01-2024
BOSTON AND LONDON, JAN. 25, 2024 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS, A GLOBAL GENE THERAPY LEA...
Více zde
KYOWA KIRIN SUCCESSFULLY COMPLETES ACQUISITION OF ORCHARD THERAPEUTICS, A GLOBAL GENE THERAPY LEADER FOR RARE DISEASES
24-01-2024
TOKYO & LONDON & BOSTON--(BUSINESS WIRE)--KYOWA KIRIN CO., LTD. (KYOWA KIRIN, TSE: 4151) A JAPAN-BAS...
Více zde
KYOWA KIRIN SUCCESSFULLY COMPLETES ACQUISITION OF ORCHARD THERAPEUTICS, A GLOBAL GENE THERAPY LEADER FOR RARE DISEASES
24-01-2024
TOKYO AND LONDON AND BOSTON, JAN. 24, 2024 (GLOBE NEWSWIRE) -- KYOWA KIRIN CO., LTD. (KYOWA KIRIN, T...
Více zde
ORCHARD THERAPEUTICS RECEIVES SWISSMEDIC APPROVAL FOR LIBMELDY IN EARLY-ONSET MLD
11-12-2023
BOSTON AND LONDON, DEC. 11, 2023 (GLOBE NEWSWIRE) -- ORCHARD THERAPEUTICS (NASDAQ: ORTX), A GLOBAL G...
Více zde
ORCHARD THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR OTL-203 IN MPS-IH
30-11-2023
PREVIOUSLY REPORTED RESULTS FROM ONGOING PROOF-OF-CONCEPT STUDY SHOWED EXTENSIVE METABOLIC CORRECTIO...
Více zde
ORCHARD THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ORCHARD THERAPEUTICS PLC - ORTX
28-11-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde
ORCHARD THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS ACCOMPLISHMENTS
13-11-2023
REPORTED $5.6 MILLION IN QUARTERLY LIBMELDY NET REVENUE AND $12.7 MILLION YEAR-TO-DATE PLANNED ACQUI...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES PRESENTATION OF ADDITIONAL POSITIVE DATA FROM PROOF-OF-CONCEPT STUDY OF OTL-203 IN MPS-IH AT ESGCT 2023
26-10-2023
NEW CLINICAL DATA BEYOND PREVIOUSLY REPORTED NEUROLOGICAL AND SKELETAL RESULTS DEMONSTRATE FAVORABLE...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES MULTIPLE PRESENTATIONS AT ESGCT 2023
24-10-2023
EIGHT PRESENTATIONS HIGHLIGHT THE DIFFERENTIATED PROFILE AND BROAD APPLICABILITY OF THE COMPANY'S HS...
Více zde
ORCHARD THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ORCHARD THERAPEUTICS PLC - ORTX
06-10-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde
ORTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF ORCHARD THERAPEUTICS PLC IS FAIR TO SHAREHOLDERS
05-10-2023
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde
KYOWA KIRIN TO ACQUIRE ORCHARD THERAPEUTICS
05-10-2023
-ORCHARD THERAPEUTICS IS A GLOBAL GENE THERAPY LEADER WITH EXPERIENCE SUCCESSFULLY DEVELOPING AND CO...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR OTL-200 IN MLD AND RECEIVES PRIORITY REVIEW
18-09-2023
PDUFA DATE SET FOR MARCH 18, 2024 OTL-200 WOULD BE THE FIRST AND ONLY TREATMENT IN THE U.S. FOR EARL...
Více zde
ORCHARD THERAPEUTICS ANNOUNCES PRESENTATION OF DATA COMPRISING THE CLINICAL PACKAGE FOR THE OTL-200 BLA IN MLD AT THE SSIEM ANNUAL SYMPOSIUM 2023
31-08-2023
ADMINISTRATION OF ONE-TIME GENE THERAPY RESULTED IN STATISTICALLY SIGNIFICANT IMPROVEMENT IN SEVERE ...
Více zde
ORCHARD THERAPEUTICS COMPLETES SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR OTL-200 IN MLD TO U.S. FDA
03-08-2023
REPORTED $6.6M IN Q2'23 LIBMELDY NET SALES, REPRESENTING THE HIGHEST QUARTER TO DATE $34.0M OF ADDIT...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2024-01-24 00:00:00 | 8-K |  | Stáhnout |
| 2024-01-23 23:00:00 | 8-K | | Stáhnout |
| 2024-01-22 00:00:00 | 8-K | | Stáhnout |
| 2024-01-21 23:00:00 | 8-K | | Stáhnout |
| 2023-12-19 00:00:00 | 8-K | | Stáhnout |
| 2023-12-18 23:00:00 | 8-K | | Stáhnout |
| 2023-12-08 00:00:00 | 8-K | | Stáhnout |
| 2023-12-07 23:00:00 | 8-K | | Stáhnout |
| 2023-11-30 00:00:00 | 8-K | | Stáhnout |
| 2023-11-29 23:00:00 | 8-K | | Stáhnout |
| 2023-11-21 00:00:00 | 8-K | | Stáhnout |
| 2023-11-20 23:00:00 | 8-K | | Stáhnout |
| 2023-11-13 00:00:00 | 8-K | | Stáhnout |
| 2023-11-13 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-12 23:00:00 | 8-K | | Stáhnout |
| 2023-11-12 23:00:00 | 10-Q | | Stáhnout |
| 2023-10-26 01:00:00 | 8-K | | Stáhnout |
| 2023-10-26 00:00:00 | 8-K | | Stáhnout |
| 2023-10-05 01:00:00 | 8-K | | Stáhnout |
| 2023-10-05 00:00:00 | 8-K | | Stáhnout |
| 2023-09-18 01:00:00 | 8-K | | Stáhnout |
| 2023-09-18 00:00:00 | 8-K | | Stáhnout |
| 2023-08-10 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-10 00:00:00 | 10-Q | | Stáhnout |
| 2023-08-03 01:00:00 | 8-K | | Stáhnout |
| 2023-08-03 00:00:00 | 8-K | | Stáhnout |
| 2023-06-26 01:00:00 | 8-K | | Stáhnout |
| 2023-06-26 00:00:00 | 8-K | | Stáhnout |
| 2023-06-14 01:00:00 | 8-K | | Stáhnout |
| 2023-06-14 00:00:00 | 8-K | | Stáhnout |
| 2023-05-23 01:00:00 | 8-K | | Stáhnout |
| 2023-05-23 00:00:00 | 8-K | | Stáhnout |
| 2023-05-15 01:00:00 | 8-K | | Stáhnout |
| 2023-05-15 01:00:00 | 10-Q | | Stáhnout |
| 2023-05-15 00:00:00 | 8-K | | Stáhnout |
| 2023-05-15 00:00:00 | 10-Q | | Stáhnout |
| 2023-03-27 01:00:00 | 8-K | | Stáhnout |
| 2023-03-27 00:00:00 | 8-K | | Stáhnout |
| 2023-03-14 00:00:00 | 10-K | | Stáhnout |
| 2023-03-13 23:00:00 | 10-K | | Stáhnout |
| 2023-03-10 00:00:00 | 8-K | | Stáhnout |
| 2023-03-09 23:00:00 | 8-K | | Stáhnout |
| 2023-03-06 00:00:00 | 8-K | | Stáhnout |
| 2023-03-05 23:00:00 | 8-K | | Stáhnout |
| 2023-02-27 00:00:00 | 8-K | | Stáhnout |
| 2023-02-26 23:00:00 | 8-K | | Stáhnout |
| 2023-02-24 00:00:00 | 8-K | | Stáhnout |
| 2023-02-23 23:00:00 | 8-K | | Stáhnout |
| 2023-02-10 00:00:00 | 8-K | | Stáhnout |
| 2023-02-09 23:00:00 | 8-K | | Stáhnout |
| 2023-01-09 00:00:00 | 8-K | | Stáhnout |
| 2023-01-08 23:00:00 | 8-K | | Stáhnout |
| 2023-01-05 00:00:00 | 8-K | | Stáhnout |
| 2023-01-04 23:00:00 | 8-K | | Stáhnout |
| 2022-12-12 00:00:00 | 8-K | | Stáhnout |
| 2022-12-11 23:00:00 | 8-K | | Stáhnout |
| 2022-11-14 00:00:00 | 8-K | | Stáhnout |
| 2022-11-14 00:00:00 | 10-Q | | Stáhnout |
| 2022-11-13 23:00:00 | 8-K | | Stáhnout |
| 2022-11-13 23:00:00 | 10-Q | | Stáhnout |
| 2022-10-06 01:00:00 | 8-K | | Stáhnout |
| 2022-10-06 00:00:00 | 8-K | | Stáhnout |
| 2022-08-04 01:00:00 | 8-K | | Stáhnout |
| 2022-08-04 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-04 00:00:00 | 8-K | | Stáhnout |
| 2022-08-04 00:00:00 | 10-Q | | Stáhnout |
| 2022-06-10 01:00:00 | 8-K | | Stáhnout |
| 2022-06-10 00:00:00 | 8-K | | Stáhnout |
| 2022-05-12 01:00:00 | 8-K | | Stáhnout |
| 2022-05-12 01:00:00 | 10-Q | | Stáhnout |
| 2022-05-12 00:00:00 | 8-K | | Stáhnout |
| 2022-05-12 00:00:00 | 10-Q | | Stáhnout |
| 2022-04-08 01:00:00 | 8-K | | Stáhnout |
| 2022-04-08 00:00:00 | 8-K | | Stáhnout |
| 2022-03-30 01:00:00 | 8-K | | Stáhnout |
| 2022-03-30 01:00:00 | 10-K | | Stáhnout |
| 2022-03-30 00:00:00 | 8-K | | Stáhnout |
| 2022-03-30 00:00:00 | 10-K | | Stáhnout |
| 2022-02-04 00:00:00 | 8-K | | Stáhnout |
| 2022-02-03 23:00:00 | 8-K | | Stáhnout |
| 2022-01-21 00:00:00 | 8-K | | Stáhnout |
| 2022-01-20 23:00:00 | 8-K | | Stáhnout |
| 2022-01-10 00:00:00 | 8-K | | Stáhnout |
| 2022-01-09 23:00:00 | 8-K | | Stáhnout |
| 2021-11-18 00:00:00 | 8-K | | Stáhnout |
| 2021-11-17 23:00:00 | 8-K | | Stáhnout |
| 2021-11-04 00:00:00 | 8-K | | Stáhnout |
| 2021-11-04 00:00:00 | 10-Q | | Stáhnout |
| 2021-11-03 23:00:00 | 8-K | | Stáhnout |
| 2021-11-03 23:00:00 | 10-Q | | Stáhnout |
| 2021-09-14 01:00:00 | 8-K | | Stáhnout |
| 2021-09-14 00:00:00 | 8-K | | Stáhnout |
| 2021-08-04 01:00:00 | 8-K | | Stáhnout |
| 2021-08-04 01:00:00 | 10-Q | | Stáhnout |
| 2021-08-04 00:00:00 | 8-K | | Stáhnout |
| 2021-08-04 00:00:00 | 10-Q | | Stáhnout |
| 2021-07-01 01:00:00 | 8-K | | Stáhnout |
| 2021-07-01 00:00:00 | 8-K | | Stáhnout |
| 2021-06-29 01:00:00 | 8-K | | Stáhnout |
| 2021-06-29 00:00:00 | 8-K | | Stáhnout |
| 2021-06-22 01:00:00 | 8-K | | Stáhnout |
| 2021-06-22 00:00:00 | 8-K | | Stáhnout |
| 2021-06-04 01:00:00 | 8-K | | Stáhnout |
| 2021-06-04 00:00:00 | 8-K | | Stáhnout |
| 2021-05-28 01:00:00 | 8-K | | Stáhnout |
| 2021-05-28 00:00:00 | 8-K | | Stáhnout |
| 2021-05-13 01:00:00 | 8-K | | Stáhnout |
| 2021-05-13 01:00:00 | 10-Q | | Stáhnout |
| 2021-05-13 00:00:00 | 8-K | | Stáhnout |
| 2021-05-13 00:00:00 | 10-Q | | Stáhnout |
| 2021-05-11 01:00:00 | 8-K | | Stáhnout |
| 2021-05-11 00:00:00 | 8-K | | Stáhnout |
| 2021-04-14 01:00:00 | 8-K | | Stáhnout |
| 2021-04-14 00:00:00 | 8-K | | Stáhnout |
| 2021-03-02 00:00:00 | 8-K | | Stáhnout |
| 2021-03-02 00:00:00 | 10-K | | Stáhnout |
| 2021-03-01 23:00:00 | 8-K | | Stáhnout |
| 2021-03-01 23:00:00 | 10-K | | Stáhnout |
| 2021-02-09 00:00:00 | 8-K | | Stáhnout |
| 2021-02-08 23:00:00 | 8-K | | Stáhnout |
| 2021-01-29 00:00:00 | 8-K | | Stáhnout |
| 2021-01-28 23:00:00 | 8-K | | Stáhnout |
| 2021-01-19 00:00:00 | 8-K | | Stáhnout |
| 2021-01-18 23:00:00 | 8-K | | Stáhnout |
| 2021-01-14 00:00:00 | 8-K | | Stáhnout |
| 2021-01-13 23:00:00 | 8-K | | Stáhnout |
| 2021-01-11 00:00:00 | 8-K | | Stáhnout |
| 2021-01-10 23:00:00 | 8-K | | Stáhnout |
| 2020-12-21 00:00:00 | 8-K | | Stáhnout |
| 2020-12-20 23:00:00 | 8-K | | Stáhnout |
| 2020-12-08 00:00:00 | 8-K | | Stáhnout |
| 2020-12-07 23:00:00 | 8-K | | Stáhnout |
| 2020-11-19 00:00:00 | 8-K | | Stáhnout |
| 2020-11-18 23:00:00 | 8-K | | Stáhnout |
| 2020-11-12 00:00:00 | 8-K | | Stáhnout |
| 2020-11-11 23:00:00 | 8-K | | Stáhnout |
| 2020-11-05 00:00:00 | 8-K | | Stáhnout |
| 2020-11-04 23:00:00 | 8-K | | Stáhnout |
| 2020-11-03 00:00:00 | 8-K | | Stáhnout |
| 2020-11-03 00:00:00 | 10-Q | | Stáhnout |
| 2020-11-02 23:00:00 | 8-K | | Stáhnout |
| 2020-11-02 23:00:00 | 10-Q | | Stáhnout |
| 2020-10-30 00:00:00 | 8-K | | Stáhnout |
| 2020-10-29 23:00:00 | 8-K | | Stáhnout |
| 2020-10-16 01:00:00 | 8-K | | Stáhnout |
| 2020-10-16 00:00:00 | 8-K | | Stáhnout |
| 2020-09-28 01:00:00 | 8-K | | Stáhnout |
| 2020-09-28 00:00:00 | 8-K | | Stáhnout |
| 2020-09-01 01:00:00 | 8-K | | Stáhnout |
| 2020-09-01 00:00:00 | 8-K | | Stáhnout |
| 2020-08-06 01:00:00 | 8-K | | Stáhnout |
| 2020-08-06 01:00:00 | 10-Q | | Stáhnout |
| 2020-08-06 00:00:00 | 8-K | | Stáhnout |
| 2020-08-06 00:00:00 | 10-Q | | Stáhnout |
| 2020-07-20 01:00:00 | 8-K | | Stáhnout |
| 2020-07-20 00:00:00 | 8-K | | Stáhnout |
| 2020-07-15 01:00:00 | 8-K | | Stáhnout |
| 2020-07-15 00:00:00 | 8-K | | Stáhnout |
| 2020-07-09 01:00:00 | 8-K | | Stáhnout |
| 2020-07-09 00:00:00 | 8-K | | Stáhnout |
| 2020-06-19 01:00:00 | 8-K | | Stáhnout |
| 2020-06-19 00:00:00 | 8-K | | Stáhnout |
| 2020-05-15 01:00:00 | 8-K | | Stáhnout |
| 2020-05-15 00:00:00 | 8-K | | Stáhnout |
| 2020-05-07 01:00:00 | 8-K | | Stáhnout |
| 2020-05-07 01:00:00 | 10-Q | | Stáhnout |
| 2020-05-07 00:00:00 | 8-K | | Stáhnout |
| 2020-05-07 00:00:00 | 10-Q | | Stáhnout |
| 2020-04-27 01:00:00 | 8-K | | Stáhnout |
| 2020-04-27 00:00:00 | 8-K | | Stáhnout |
| 2020-03-31 01:00:00 | 8-K | | Stáhnout |
| 2020-03-31 00:00:00 | 8-K | | Stáhnout |
| 2020-03-20 00:00:00 | 8-K | | Stáhnout |
| 2020-03-19 23:00:00 | 8-K | | Stáhnout |
| 2020-02-27 00:00:00 | 8-K | | Stáhnout |
| 2020-02-27 00:00:00 | 10-K | | Stáhnout |
| 2020-02-26 23:00:00 | 8-K | | Stáhnout |
| 2020-02-26 23:00:00 | 10-K | | Stáhnout |
| 2020-02-03 00:00:00 | 8-K | | Stáhnout |
| 2020-02-02 23:00:00 | 8-K | | Stáhnout |
| 2020-01-29 00:00:00 | 8-K | | Stáhnout |
| 2020-01-28 23:00:00 | 8-K | | Stáhnout |
| 2020-01-13 00:00:00 | 8-K | | Stáhnout |
| 2020-01-12 23:00:00 | 8-K | | Stáhnout |
